Amwill Healthcare is a derma-cosmetic development company, that develops dermatological, cosmeceutical and aesthetical products. It is developin solutions for dermatological discorders like acne, fungal infections, anti-ageing, histaminic, perspiration, trichology, and vitiligo.
Key services;
- Development and contract manufacturing of generic dermatological solutions; and
- Developing and formulating solutions to specific dermatological problem
Product Portfolio
- Skin Care solutions
- Hair Care Solutions
- Personal Care and hygiene solutions
All work such as manufacturing, prototype development, and distribution is outsourced by the company. For this, the company is associated with contract manufacturers. It has a storage and distribution chain with M/s Amderma Healthcare.
Amwill Healthcare SME IPO Details
| IPO Opening Date | 5 Feb 2025 |
| IPO Closing Date | 7 Feb 2025 |
| Issue Price | ₹ 105 to 111 Per Share |
| Market Lot | 1200 Shares |
| 1 Lot Amount | ₹ 133200 |
| Small HNI Lot | ₹ 2 to10 Lakhs |
| Big HNI Lot | ₹ 10 + Lakhs |
| Issue Size | ₹ 59.98 Cr |
| Offer for sale | ₹ 11.10 Cr |
| Fresh Issue | ₹ 48.88 Cr |
| IPO Listing at | BSE/SME |
| Allotment Date | 10 Feb 2025 |
| Refund Initiation | 11 Feb 2025 |
| Credit Of Shares to Demat Account | 11 Feb 2025 |
| Listing Dates | 12 Feb 2025 |
| Allotment Status check at BSE | Click here |
| Allotment Status check at NSE | Click here |